107 related articles for article (PubMed ID: 1332239)
1. Case for the panel. Visceral leishmaniasis: I. Unusual interrelationships between immature erythrocytes and both parasites and mature erythrocytes.
el-Shoura SM
Ultrastruct Pathol; 1992; 16(5):593-9. PubMed ID: 1332239
[No Abstract] [Full Text] [Related]
2. Electron microscopy of Leishmania donovani in splenic aspirates from patients with visceral leishmaniasis during treatment with sodium stibogluconate.
Chulay JD; Fawcett DW; Chunge CN
Ann Trop Med Parasitol; 1985 Aug; 79(4):417-29. PubMed ID: 3000304
[TBL] [Abstract][Full Text] [Related]
3. Combination therapy using sodium antimony gluconate in stearylamine-bearing liposomes against established and chronic Leishmania donovani infection in BALB/c Mice.
Pal S; Ravindran R; Ali N
Antimicrob Agents Chemother; 2004 Sep; 48(9):3591-3. PubMed ID: 15328135
[TBL] [Abstract][Full Text] [Related]
4. Fine structure of Leishmania donovani in bone marrow aspirates from a patient with visceral leishmaniasis before and during treatment with sodium stibogluconate.
el-Shoura SM; Sheikha AK
Trop Med Parasitol; 1991 Jun; 42(2):119-26. PubMed ID: 1654589
[TBL] [Abstract][Full Text] [Related]
5. Visceral leishmaniasis: a difficult diagnosis and unusual causative agent.
Oren R; Schnur LF; Ben Yehuda D; Mayner V; Okon E; Rachmilewitz EA
J Infect Dis; 1991 Oct; 164(4):746-9. PubMed ID: 1654358
[TBL] [Abstract][Full Text] [Related]
6. Holiday souvenirs from the Mediterranean: three instructive cases of visceral leishmaniasis.
Buonomano R; Brinkmann F; Leupin N; Boscacci R; Zimmermann A; Müller N; Fux CA
Scand J Infect Dis; 2009; 41(10):777-81. PubMed ID: 19593691
[TBL] [Abstract][Full Text] [Related]
7. Increased parasite surface antigen-2 expression in clinical isolates of Leishmania donovani augments antimony resistance.
Bhandari V; Kumar D; Verma S; Srividya G; Negi NS; Singh R; Salotra P
Biochem Biophys Res Commun; 2013 Nov; 440(4):646-51. PubMed ID: 24103752
[TBL] [Abstract][Full Text] [Related]
8. Visceral leishmaniasis in the BALB/c mouse: antimony tissue disposition and parasite suppression after the administration of free stibogluconate.
Collins M; Carter KC; Baillie AJ
Ann Trop Med Parasitol; 1992 Feb; 86(1):35-40. PubMed ID: 1319700
[TBL] [Abstract][Full Text] [Related]
9. [A case of antimony resistant kala-azar cured with amphotericin B].
Chen SB; Yang CM; Zhang CJ
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2007 Jun; 25(3):inside front page. PubMed ID: 18038767
[No Abstract] [Full Text] [Related]
10. Kala azar--diagnostic dilemma.
Raman TS; Ahuja SA; Mani KV; Jalpota YP; Adaval SK
Indian Pediatr; 1992 Aug; 29(8):1036-9. PubMed ID: 1334051
[No Abstract] [Full Text] [Related]
11. Positive response to sodium antimony gluconate administration in visceral leishmaniasis seropositive patients.
Chowdhury S; Haque F; al-Masum A; el Harith A; Karim E
Am J Trop Med Hyg; 1991 Apr; 44(4):390-3. PubMed ID: 1645929
[TBL] [Abstract][Full Text] [Related]
12. Resistance of Leishmania donovani to sodium stibogluconate is related to the expression of host and parasite gamma-glutamylcysteine synthetase.
Carter KC; Hutchison S; Henriquez FL; Légaré D; Ouellette M; Roberts CW; Mullen AB
Antimicrob Agents Chemother; 2006 Jan; 50(1):88-95. PubMed ID: 16377672
[TBL] [Abstract][Full Text] [Related]
13. Pentavalent antimony-mannan conjugate therapy of experimental visceral leishmaniasis.
Roberts WL; Hariprashad J; Rainey PM; Murray HW
Am J Trop Med Hyg; 1996 Oct; 55(4):444-6. PubMed ID: 8916804
[TBL] [Abstract][Full Text] [Related]
14. Leishmania species, drug unresponsiveness and visceral leishmaniasis in Bihar, India.
Thakur CP; Dedet JP; Narain S; Pratlong F
Trans R Soc Trop Med Hyg; 2001; 95(2):187-9. PubMed ID: 11355558
[TBL] [Abstract][Full Text] [Related]
15. Visceral and cutaneous leishmaniasis comparative ultrastructure of host-parasite interactions.
el-Shoura SM; Sheikha AK; Bahamdan KA; Tallab TM; Hassounah OA
J Egypt Soc Parasitol; 1995 Dec; 25(3):861-76. PubMed ID: 8586879
[TBL] [Abstract][Full Text] [Related]
16. Treatment of Indian kala-azar with pentavalent antimony.
Arya SC
Lancet; 1995 Mar; 345(8949):584. PubMed ID: 7776791
[No Abstract] [Full Text] [Related]
17. Studies on stibanate resistant Leishmania donovani isolates of Indian origin.
Pal S; Mandal A; Duttagupta S
Indian J Exp Biol; 2001 Mar; 39(3):249-54. PubMed ID: 11495284
[TBL] [Abstract][Full Text] [Related]
18. The response of Kenyan kala-azar to treatment with sodium stibogluconate.
Rees PH; Kager PA; Wellde BT; Hockmeyer WT
Am J Trop Med Hyg; 1984 May; 33(3):357-61. PubMed ID: 6329010
[TBL] [Abstract][Full Text] [Related]
19. Cationic liposomal sodium stibogluconate (SSG), a potent therapeutic tool for treatment of infection by SSG-sensitive and -resistant Leishmania donovani.
Sinha R; Roychoudhury J; Palit P; Ali N
Antimicrob Agents Chemother; 2015 Jan; 59(1):344-55. PubMed ID: 25367907
[TBL] [Abstract][Full Text] [Related]
20. Sodium stibogluconate-sensitive visceral leishmaniasis in the non-endemic hilly region of Uttarakhand, India.
Verma SK; Ahmad S; Shirazi N; Kusum A; Kaushik RM; Barthwal SP
Trans R Soc Trop Med Hyg; 2007 Jul; 101(7):730-2. PubMed ID: 17382981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
